Consumer staples are often viewed as a single defensive sleeve, yet the exchange-traded funds tracking this space can differ markedly in approach. IYK, PSCC, and RSPS all deliver exposure to food, beverage, household, and personal-care companies, but they reflect three separate strategies: a large-cap, market-cap-weighted benchmark; a small-cap satellite; and an equal-weighted large-cap alternative. Comparing them shows how index selection, weighting, and size exposure can shape sector access, costs, risk, and positioning.
IYK tracks the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index through a market-capitalization-weighted approach focused on large U.S. staples names. The fund typically holds 53 to 58 positions, with significant weight in names such as PG, KO, PM, PEP, and MO. Its top 10 holdings represent about two-thirds of assets, which introduces notable concentration. Food, beverage, and tobacco account for more than half the portfolio, followed by household and personal products. The expense ratio stands at 0.38%. The fund is non-diversified yet benefits from scale and narrow trading spreads. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
PSCC follows the S&P SmallCap 600 Capped Consumer Staples Index, a float-adjusted, market-cap-weighted collection of smaller U.S. staples companies. It holds around 30 stocks, led by holdings such as LW, CAG, TAP, PSMT, and CPB. Food products and consumer staples distribution and retail form the largest industry groups. The expense ratio is 0.29%, the lowest among the three. The fund rebalances quarterly. Its smaller asset base, limited holdings, and wider spreads result in lower liquidity and greater volatility than its large-cap counterparts.
RSPS tracks the S&P 500 Equal Weight Consumer Staples Index, assigning equal weights to each S&P 500 staples constituent and rebalancing quarterly. With roughly 37 to 39 holdings, no single position exceeds about 3% of assets, which reduces concentration risk compared with cap-weighted peers. Top holdings typically include KR, COST, PM, PG, and WMT, each near the 3% level. The expense ratio is 0.40%. This equal-weight approach shifts emphasis away from the largest names toward mid-sized players, which can influence dividend and performance characteristics.
All three ETFs operate in the consumer staples sector, classified as defensive under GICS. Demand for everyday goods tends to remain stable across cycles, yet the space faces ongoing pressures from inflation, changing consumer tastes, grocery consolidation, and private-label competition. Input-cost swings and supply-chain issues have particularly affected smaller names in PSCC, while larger companies have used pricing power and cost controls to protect margins. These dynamics influence each fund differently based on its size and weighting style. From what I see, this is important because structural differences can lead to varied outcomes even within the same sector.
Recent periods show divergence that aligns with each fund’s construction. IYK has tended to deliver steadier results, reflecting its low market beta and focus on stable mega-caps. PSCC has experienced sharper moves and greater volatility, consistent with small-cap sensitivity to earnings and liquidity conditions. RSPS falls in between on volatility, though its equal-weight tilt and higher fee have influenced relative results. Differences in concentration, size exposure, and rebalancing explain most of the variation.
When evaluating sector ETFs like these, I often rely on Tickeron’s AI Screener to quickly compare liquidity, volatility, and risk metrics across similar funds. It helps me scan for patterns and confirm how structural features translate into real-world behavior without spending hours on manual analysis. This tool has become a regular part of my process for narrowing choices in defensive areas such as consumer staples.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day RSI Oscillator for IYK moved out of overbought territory on October 23, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 instances where the indicator moved out of the overbought zone. In 31 of the 38 cases the stock moved lower in the days that followed. This puts the odds of a move down at 82%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IYK as a result. In 61 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.
The Moving Average Convergence Divergence Histogram (MACD) for IYK turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 30 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
IYK broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.
Following a +1.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 266 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 229 of 305 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows